Login / Signup

Artificial intelligence, drug repurposing and peer review.

Jeremy M LevinTudor I OpreaSagie DavidovichThomas ClozelJohn P OveringtonQuentin VanhaelenCharles R CantorEvelyne BischofAlex Zhavoronkov
Published in: Nature biotechnology (2020)
Keyphrases
  • artificial intelligence
  • machine learning
  • big data
  • deep learning
  • adverse drug
  • drug induced